OntologiesCurators at RGD make annotations to genes, QTLs and strains using standardized vocabularies/ontologies. Your search returned annotations to the terms below.ChEBI: ChEBI Ontology
(Z)-N-(sulfonatooxy)alkanimidothioate
12,15-dimethoxycyclocalopin A
4-(dimethylamino)-3-[(phenylmethoxyamino)methylideneamino]-2-thieno[2,3-b]pyridinecarboxylic acid ethyl ester
aminophosphonate
Benzoxazine-6-carboxylic acid
Beta-Ionol
carboxamide
CGP72383
cyanate
cyanato group
Flavichalasine O
fulminate
halocynthiaxanthin
hemiaminal ether
imidate
isocyanato group
isofulminic acid
mercury difulminate
monocarboxylic acid amide
N'-[5-(3,4-dimethylanilino)-1H-1,2,4-triazol-3-yl]-N-hydroxymethanimidamide
N-(1,3-benzodioxol-5-ylmethyl)-6-chloro-4-quinazolinamine
N-[(2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3S,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]acetamide
N-[(3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-3-Acetamido-5-[(2S,3S,4S,5R,6R)-4-[(2S,3S,4S,5S,6R)-3,5-bis[[(2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy]-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3S,4S,5S,6R)-3,5-bis[[(2S,3R,4R,5S,6R)-3-acetamido-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy]-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,5-dihydroxyoxan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,4-dihydroxy-6-[[(2R,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-3-yl]acetamide
N-[(4R,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4R,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7R,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8R)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-[(4S,7S,8S)-5-[(2-fluorophenyl)-oxomethyl]-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]butanamide
N-hydroxy-2-methylpropanamine
N-hydroxyglycine
N-substituted aminocarbonyl group
N-sulfonylcarboxamide
N-sulfonylimidate
nitridooxidocarbon(.)
nitridooxidocarbonate(.2-)
nitrile oxide
nitrone
nitrosoperoxycarbonate(1-)
O-Acetylcyclocalopin A
oxime anion
oxime O-ether
Penochalasin I
Pulveraven A
Sclerotiorumin C
sulfonylimidate
tectoridin
tertiary carboxamide
TG(15:0/18:1(11Z)/15:0)
EFO: Experimental Factor Ontology
carboxamide
CCR4-NOT transcription complex subunit 1
CCR4-NOT transcription complex subunit 1 (human)
CCR4-NOT transcription complex subunit 9
CCR4-NOT transcription complex subunit 9 (human)
chronic recurrent multifocal osteomyelitis
CNOT1 (human)
CNOT9 (human)
nitric oxide synthase 3
nitric oxide synthase 3 (human)
GO: Cellular Component
CCR4-NOT complex
GO: Molecular Function
poly(A)-specific ribonuclease activity
RDO: RGD Disease Ontology
holoprosencephaly 12
Intellectual Developmental Disorder with Speech Delay, Autism, and Dysmorphic Facies
Neurodevelopmental Disorders
Vissers-Bodmer syndrome
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



















